v3.26.1
Note 13 - Stock-based Compensation
9 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(13) Stock-Based Compensation

 

We have granted equity incentives to employees and directors in the form of stock options and restricted stock awards. The total stock-based compensation expense for all equity incentives was $245 thousand and $152 thousand for the three months ended March 31, 2026, and March 31, 2025, respectively. The total stock-based compensation expense for all equity incentives was $740 thousand and $629 thousand for the nine months ended March 31, 2026, and March 31, 2025, respectively.

 

Stock Options

 

The Company’s stock option activity for the nine months ended March 31, 2026, is as follows:

 

  Shares  Weighted Average Exercise Price 

Outstanding at June 30, 2025

  213,113  $15.36 

Granted

  78,250   4.84 

Exercised

      

Canceled or expired

  (56,937)  7.62 

Outstanding at March 31, 2026

  234,426  $11.10 

 

The aggregate intrinsic value was $0 for all of options exercisable and for all unvested options at March 31, 2026, because the fair value of the Company’s common stock was less than the exercise prices of these options.

 

The table below details the Company’s stock options outstanding as of March 31, 2026:

 

Range of Exercise prices  Number Outstanding  Options Outstanding Weighted-Average Remaining Contractual Life (Years)  Weighted-Average Exercise Price  Number Exercisable  Options Exercisable Weighted-Average Exercise Price 
$4.73 - 9.69   84,600   9.16  $5.56   23,169  $6.18 
$10.10 - 11.27   75,130   7.49   10.12   50,490   10.12 
$11.51 - 19.2   72,755   7.45   14.32   36,832   18.95 
$159 - 175.50   1,941   1.11   170.33   1,941   170.33 
$4.73 - 175.50   234,426   8.03   11.10   112,432  $14.97 

 

Compensation costs recognized related to stock option awards were $73 thousand and $126 thousand for each of the three months ended March 31, 2026, and 2025, respectively. Compensation costs recognized related to stock option awards were $464 thousand and $480 thousand for each of the nine months ended March 31, 2026, and 2025, respectively. The remaining stock-based compensation expense of $514 thousand related to stock options will be recognized over a weighted-average period of 1.59 years.

 

Restricted Stock

 

The Company’s restricted stock activity for the nine months ended March 31, 2026, is as follows:

 

  

Shares

  

Weighted Average Grant Date Fair Value

 

Outstanding at June 30, 2025

  85,834  $14.11 

Granted

        

Vested

        

Canceled or expired

  (4,050)  10.41 

Outstanding at March 31, 2026

  81,784  $17.32 

 

Stock compensation expenses related to restricted stock were $172 thousand and $26 thousand for the three months ended March 31, 2026, and 2025, respectively. Stock compensation expenses related to restricted stock were $246 thousand and $149 thousand for the nine months ended March 31, 2026, and 2025, respectively. The remaining stock-based compensation expense of $419 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 1.72 years.